Pfizer is raising the ... Of that total, $4.5 billion in net cost savings will be realized by the end of this year from an ongoing cost-realignment program, the company said in its first-quarter ...

Photo: ABC News Pfizer on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business postpandemic.

Pfizer adds the guidance does not include the potential impact of future changes in trade and tariff policies. Cost-Cutting Initiatives ... With the new target, total program savings are expected ...

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...

(Reuters) -Pfizer said ... LEANING ON COST SAVINGS The company said it now expects about $7.7 billion in savings by the end of 2027 from its cost-cutting programs. That includes an additional ...

Pfizer has fleshed out some more of the details of its wide-ranging cost-cutting drive announced last month, revealing that around 500 jobs will go in the UK, including at its R&D site at Sandwich ...